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Introduction
Pancreatic ductal adenocarcinoma (PDAC)
is an aggressive and lethal form of
pancreatic cancer, ranking fourth in
cancer-related deaths in the US. PDAC is
heterogenous in its biophysical features
and clinical outcomes.1 Characterization of
tumors into distinct biological subtypes
would enable more personalized therapies.
The “delta” method is used to characterize
the interface between the border of tumor
and healthy pancreas on CT scans before
treatment. High delta tumors are more
conspicuous on CT scans, and patients
with these high delta phenotypes have
earlier distant metastasis, and shorter
overall survival than patients with tumors
classified as low delta, which are less
conspicuous on CT.2

A.

Materials and Methods
Using 20 tumor samples, ten classified as high delta and ten as low delta, we first
consulted with a pathologist to identify tissue regions of high cancer density. Using
these regions, we will continue gathering data with the 10X Genomics ST protocol.
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Figure 4. Average expression and percent expressed of
known classical (A) and basal-like (B) gene markers in
high and low delta tumors.
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Figure 2. Pathway displaying how tumor tissues were evaluated and prepared to obtain sequencing and
spatial expression information.
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Results
Currently, four samples are awaiting to be sequenced and 16 are in the process of
hybridization, ligation and barcoding. Two preliminary FFPE tissue samples were
analyzed to compare low and high delta tumors.
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Figure 5. Correlation between genetic clusters and
morphology.

Conclusions

Figure 1. Arrows pointing to highly conspicuous
tumor, or high delta (A) and less conspicuous PDAC
tumor, or low delta (B) on CT.2

Our preliminary data suggest potential
differences in spatial transcriptional profiles
and subtype marker expression between
high and low delta tumors, which is vital
information in developing treatment plans
personalized for each patient. We will
continue our analyses and validate results
that may be actionable in clinic.

Through molecular characterization, two
PDAC subtypes are known: classical,
which are frequently surgically resectable,
and basal-like, with poorer clinical
outcome.3
There is a gap in knowledge regarding the
transcriptomic differences between high
and low delta tumors. Here we aim to
investigate the spatial transcriptomic (ST)
differences between high and low delta
tumors. By using ST, we will measure gene
activity and map where the gene clusters
are on the tissue.
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